NASDAQ : AKYA

Akoya Biosciences, Inc.

$1.29 USD

-$0.07 (-5.15%)

Volume
715.25K
Average Volume
582.12K
Market Capitalization
$64.44M
P/E Ratio
-1.15
Dividend Yield
0.00%
Price Target
$6.00
Year High
$3.42
Year Low
$0.93
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.61
Company Overview

NASDAQ

Brian McKelligon

Medical - Instruments & Supplies

Healthcare

AKYA

205

US

USD

https://www.akoyabio.com

855 896 8401

00974H104

0001711933

Liquidity Metrics

11.08

2.61

1.78

0.40

0.00

Sales & Valuation

$81.67M

0.79

8.39

-1.38

-0.94

Profitability

-$1.12

-$55.36M

-67.79%

-67.61%

-180.44%

-44.29%

P/E Metrics

-1.15

-0.03

-0.03

Analyst Price Target & Rating

$6.00

$7.50

$2.40

N/A

0/5

9 Analysts

-78.50%

Poll Results

About Akoya Biosciences, Inc. (NASDAQ:AKYA) Stock

Akoya Biosciences, Inc. is a prominent life sciences technology firm dedicated to furnishing advanced spatial biology solutions. The company's mission is to significantly advance both discovery and clinical research across numerous global regions, including North America, Asia Pacific, Europe, the Middle East, and Africa. Their core product lineup features the PhenoCycler instrument, a compact benchtop fluidics system designed to integrate seamlessly with a microscope for automated image acquisition. Complementing this is the PhenoImager platform, which empowers researchers to intricately visualize, analyze, quantify, and characterize cells directly within diverse tissue samples—such as fresh frozen or FFPE sections and tissue microarrays—through an efficient, automated, and high-throughpu ... t process. Akoya also supplies the essential reagents for these PhenoCycler and PhenoImager systems, alongside providing specialized biopharmaceutical services. Beyond hardware, Akoya offers a robust suite of software tools. Proxima serves as a cloud-based platform for the secure storage, comprehensive analysis, and collaborative sharing of spatial data. For image interpretation, the inForm Tissue software delivers automated analysis to precisely visualize and quantify biomarkers within tissue sections. Further streamlining data workflows, Phenoptr facilitates the consolidation and in-depth analysis of output tables generated by inForm. Finally, phenoptrReports is a user-friendly software application that generates intuitive reports and visualizations from phenoptr output, presented via an easy-to-navigate graphical user interface. Established in 2015, Akoya Biosciences maintains its corporate headquarters in Marlborough, Massachusetts.

Frequently Asked Questions

What is the current Akoya Biosciences, Inc. (AKYA) stock price?

Akoya Biosciences, Inc.(NASDAQ:AKYA) stock price is $1.29 in the last trading session. During the trading session, AKYA stock reached the peak price of $3.42 while $0.931 was the lowest point it dropped to. The percentage change in AKYA stock occurred in the recent session was --5.15% while the dollar amount for the price change in AKYA stock was -$0.07.

AKYA's industry and sector of operation?

The NASDAQ listed AKYA is part of Medical - Instruments & Supplies industry that operates in the broader Healthcare sector.

Who are the executives of AKYA?

Niro Ramachandran | Chief Business Officer
John Frederick Ek | Chief Financial Officer & Principal Accounting Officer
Jennifer Kamocsay | Chief Legal Officer
Anthony Catalano | Senior Vice President of Operations
Brian McKelligon | President, Chief Executive Officer & Director

How many employees does AKYA have?

Number of AKYA employees currently stands at 205. AKYA operates from 100 Campus Drive, Marlborough, MA 01752, US.

Link for AKYA official website?

Official Website of AKYA is: https://www.akoyabio.com

How do I contact AKYA?

AKYA could be contacted at phone #855 896 8401 and can also be accessed through its website. AKYA operates from 100 Campus Drive, Marlborough, MA 01752, US.

How many shares of AKYA are traded daily?

The average number of AKYA shares traded daily for last 3 months was 582.12K.

What is the market cap of AKYA currently?

The market value of AKYA currently stands at $64.44M with its latest stock price at $1.29